# Cellebrite DI (CLBT) — Earnings

CLBT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/clbt/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.02 |
| EPS estimate | $0.06 |
| EPS surprise | −66.33% |
| Revenue surprise | −0.28% |
| Revenue | $131.1M |
| Revenue estimate | $131.5M |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1854587/000121390026089232/ea0302091-6k_cellebrite.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/99959036-bf68-2f02-9fe5-3251b5dbbd7d.html) |

Cellebrite reported Q2 2026 results on August 13, 2026. Earnings per share were $0.02, 66.33% below the $0.06 estimate. Revenue of $131.1 million was just under the $131.5 million consensus. Compared with Q2 2025, EPS fell from $0.08, while revenue rose about 16% from $113.3 million.

Revenue has trended up. The latest quarter is the highest in the table, about twice the $65.9 million of Q3 2021, and annual revenue rose about 19% in 2025 to $475.6 million. Earnings have been less steady. Annual EPS went from $0.61 in 2022 to losses of $0.43 in 2023 and $1.39 in 2024, a year that included a $0.99 loss in Q3, then back to a $0.31 profit in 2025. The first half of 2026 totals $0.06 per share, against $0.15 a year earlier. Cellebrite missed the EPS estimate in each of the last four quarters and beat it in nine of the last 20.

Q3 reports came between November 6 and November 17 in each of the past five years. That points to mid-November 2026 for the next report. It will show how EPS compares with the $0.08 earned in Q3 2025.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 13, 2026 | $0.06 | $0.02 | -66.33% | $131.5M | $131.1M |
| Q1 2026 | May 14, 2026 | $0.05 | $0.04 | -25.65% | $127.0M | $128.3M |
| Q4 2025 | Feb 11, 2026 | $0.10 | $0.08 | -17.86% | $126.1M | $128.8M |
| Q3 2025 | Nov 12, 2025 | $0.09 | $0.08 | -15.34% | $123.0M | $126.0M |
| Q2 2025 | Aug 14, 2025 | $0.08 | $0.08 | 3.76% | $112.3M | $113.3M |
| Q1 2025 | May 14, 2025 | $0.05 | $0.07 | 33.33% | $109.3M | $107.5M |
| Q4 2024 | Feb 13, 2025 | $0.07 | $0.08 | 16.45% | $107.3M | $109.0M |
| Q3 2024 | Nov 6, 2024 | $0.07 | −$0.99 | -1425.30% | $102.1M | $106.9M |
| Q2 2024 | Aug 15, 2024 | $0.04 | −$0.12 | -430.58% | $91.9M | $95.7M |
| Q1 2024 | May 23, 2024 | $0.02 | −$0.36 | -1587.60% | $85.3M | $89.6M |
| Q4 2023 | Feb 15, 2024 | $0.03 | −$0.08 | -350.00% | $85.6M | $93.0M |
| Q3 2023 | Nov 14, 2023 | $0.03 | $0.03 | 17.19% | $82.1M | $84.2M |
| Q2 2023 | Aug 8, 2023 | $0.02 | −$0.17 | -1218.42% | $72.5M | $76.7M |
| Q1 2023 | May 10, 2023 | $0.01 | −$0.21 | -2758.23% | $69.4M | $71.2M |
| Q4 2022 | Feb 15, 2023 | $0.05 | $0.04 | -23.81% | $74.5M | $74.0M |
| Q3 2022 | Nov 17, 2022 | $0.01 | $0.13 | 2500.00% | $72.1M | $71.7M |
| Q2 2022 | Aug 11, 2022 | $0.01 | $0.17 | 1150.00% | $69.1M | $62.6M |
| Q1 2022 | May 12, 2022 | $0.01 | $0.27 | 2060.00% | $62.6M | $62.4M |
| Q4 2021 | Feb 16, 2022 | $0.02 | $0.25 | 1328.57% | $64.0M | $67.9M |
| Q3 2021 | Nov 10, 2021 | $0.01 | $0.08 | 1094.03% | $59.3M | $65.9M |

## Frequently Asked Questions

### When did Cellebrite DI (CLBT) last report earnings?

Cellebrite DI last reported on Aug 13, 2026, covering fiscal Q2 2026.

### Did CLBT beat earnings estimates?

No. Cellebrite DI reported EPS of $0.02 for Q2 2026 against a $0.06 estimate — a 66.33% miss.

### How much revenue did CLBT report last quarter?

Cellebrite DI reported $131.1M in revenue for Q2 2026, against a consensus estimate of $131.5M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).